⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLSA News
Tiziana Life Sciences Ltd. Common Shares
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
globenewswire.com
TLSA
RARE Drug Development Symposium Marks 10th Anniversary with Dedicated Pitch Sessions and The Theme and Call to Action to Align Advocates, Science and Industry
prnewswire.com
BIIB
REGN
GILD
BTE
BROS
BFLY
BCTX
BCRX
BTAI
ALRS
CAPR
CRIS
CYCN
EXAS
FATE
GNTX
HRMY
INCY
IONS
KODK
LAKE
LULU
MRNA
NBIX
NTRA
OCGN
ORGN
PGEN
PLRX
RARE
RGNX
RXRX
SAVA
SGMO
SNOW
SRPT
STEM
TGTX
TLSA
TXG
VRTX
ZETA
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
globenewswire.com
TLSA
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
globenewswire.com
TLSA
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
globenewswire.com
TLSA
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
globenewswire.com
TLSA
Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial
globenewswire.com
TLSA
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
globenewswire.com
TLSA
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
globenewswire.com
TLSA
Eilinio visuotinio akcininkų susirinkimo, įvykusio 2026 m. balandžio 24 d., sprendimai
globenewswire.com
TLSA